Posts by: John A
Stocks DD has an update on Fusilev dosing study for treating mucositis in Folotyn patients -> Link
More can be found in our partner site Stocks DD
Bluemountain now seems to be the largest shareholder of TARO. More can be found in our partner site Stocks DD
Can be found in our partner site Stocks DD -> Link
We all know much of Ackman’s thesis depends on would-be distributors becoming aware of their odds of success in Herbalife. To that extent it matters how many people googled the word Herbalife or are internet savvy.
Check it in partner’s site for more info-> http://stocksdd.blogspot.com/2013/01/google-trends-on-keywords-herbalife.html
Partner site Stocks DD has info on this – > Link
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard
